![](/mthumb.php?src=http://www.global-bankers.com/uploads/articles/6596483abd338_Goldman_Sachs_yt.jpg&w=730&h=480)
Goldman Sachs Asset Management raises $650 million for life sciences fund
The fund, West Street Life Sciences I, will specifically target early to mid-stage therapeutic companies with multi-asset portfolios as well as tools and diagnostics firms.
The fund, West Street Life Sciences I, will specifically target early to mid-stage therapeutic companies with multi-asset portfolios as well as tools and diagnostics firms.